NEJM 新英格兰医学杂志· C. Michael Gibson P. Gabriel Steg M. Cecilia Bahit Rasha Al-Lamee Shamir R. Mehta Roxana Mehran Jeffrey I. Weitz Shinya Goto Jose Carlos Nicolau Renato D. Lopes Junbo Ge Nebojsa Tasic Dominick J. Angiolillo Suzanne J. Baron Ajay J. Kirtane Denis Xavier Satoshi Yasuda Basil S. Lewis Duk-Woo Park Jan H. Cornel Thomas W. Johnson Jaroslaw Trebacz Daniel Duerschmied Christoph Bode Bela Merkely Maria Dorobantu Dragos Vinereanu Zuzana Motovska Hector Bueno Jose Luis Lopez-Sendon Gregory Ducrocq Giuseppe Ambrosio Lesley Burgess Allan Bohm Chern-En Chiang Joao Morais Alan Fong Umit Guray Jose Luis Leiva-Pons Pascal Vranckx Harvey D. White Sasko Kedev Marco Valgimigli Duško Cerovec Dimitris Tousoulis Gemma Figtree Thuong Dung Ho Rody G. Sy Morten Bøttcher Kurt Huber Rimvydas Slapikas Andrejs Erglis Jack Wei Chieh Tan Christian Pincetti Karen S. Pieper Kenneth W. Mahaffey Carolyn S.P. Lam S. Claiborne Johnston Graeme J. Hankey Jennifer S. Li Luke Zheng Ronald Aronson Danshi Li Ravi Notani Philippe Vieira Pires Thomas J. Povsic Alistair C. Lindsay Alexei Plotnikov Hsiaowei Deng Elliot S. Barnathan and Robert A. Harringtonthe LIBREXIA ACS Committees and Investigators*·· 2026-08-29AI 评分61
LIBREXIA ACS 试验:Milvexian 联合抗血小板治疗用于急性冠脉综合征
Milvexian with Antiplatelet Therapy after Acute Coronary Syndrome Event
AI 导读
该研究在 NEJM 发表,由 LIBREXIA ACS 委员会和调查员完成,考察 Milvexian 联合抗血小板治疗用于急性冠脉综合征事件后的疗效与安全性,当前材料仅包含标题与出版信息,未提供具体试验结果。
来源:NEJM 新英格兰医学杂志 · nejm.org